What Dotmatics does

Dotmatics is a scientific R&D software company that builds the Luma Scientific Intelligence Platform, an AI-powered data and workflow management system serving pharmaceutical, biotechnology, chemicals and materials science, and academic research organizations. The platform is architected around structured, ontology-backed scientific data captured at the point of work, with connectivity to more than 500 laboratory instruments and 200 data sources. Specialized modules address biologics drug discovery (BioGlyph Luma for protein design, Geneious Luma for antibody discovery), small molecule discovery, flow cytometry (FCS Express Luma, OMIQ Luma), electronic lab notebooks, and data visualization (Vortex). In May 2026, the company launched Luma Agent, an agentic AI capability that enables scientists to plan and execute complex multi-step research work using natural language while maintaining traceable data lineage required for regulated environments.

The company operates a subscription-based enterprise SaaS model with modular pricing, quote-based contracts, and annual billing cadence. Revenue is generated primarily through direct enterprise sales targeting large pharmaceutical and biotech accounts, complemented by a product-led growth motion via self-service demos, webinars, and partner-driven integrations. Named enterprise customers span BASF Agricultural Solutions, Cancer Research UK Beatson Institute, Krystal Biotech, Addpharma, and CRODA, with deployments across biologics, small molecule, agricultural R&D, and academic research. The company has pursued an aggressive acquisition strategy, integrating SoftGenetics (June 2023), EasyPanel (July 2024), Virscidian (September 2024), and other prior targets to broaden its scientific domain coverage.

In July 2025, Siemens AG completed a $5.1 billion acquisition of Dotmatics, integrating it into Siemens' Digital Industries Software business and expanding Siemens' total addressable market by $11 billion in life sciences. Post-acquisition, Dotmatics operates as a wholly-owned subsidiary with expected medium-term revenue synergies of approximately $100 million annually, accelerating to over $500 million long-term, and projected FY2025 revenue above $300 million with adjusted EBITDA margin exceeding 40 percent. The platform's strategic partnerships with Databricks and the Model Context Protocol further position it as an interoperable AI backbone for scientific research workflows.

Name

Dotmatics

Legal name

Dotmatics Ltd.

Website

https://dotmatics.com

Company type

Private

Founded year

1987

Operating status

Acquired

Headcount range

501–1,000 employees

Short description

Dotmatics provides the Luma Scientific Intelligence Platform, an AI-powered R&D software system with structured scientific data, lab instrument integration, and domain-specific modules for biologics, small molecule, flow cytometry, and materials science, serving pharmaceutical, biotech, and academic research organizations globally.

Ownership category

akta.pro rank

Product category

Life Sciences R&D Software

NAICS

Computer Systems Design and Related Services (54151), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL), Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)

Keywords

• Scientific R&D software
• Life sciences informatics
• Electronic lab notebook
• Drug discovery platform
• Lab data integration

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Enterprise Software Licenses and Subscriptions: Subscription-based SaaS model providing access to the Luma Scientific Intelligence Platform and associated modules. Revenue generated through annual or multi-year contracts with life sciences companies, pharmaceutical firms, and research institutions. Enterprise deals are characterized by land-and-expand dynamics as organizations adopt additional modules.
2. Platform Modules and Add-ons: Modular pricing structure allowing customers to purchase specific capabilities such as flow cytometry analysis, antibody discovery, electronic lab notebooks, and data visualization tools. Enables upselling as research needs expand.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Dotmatics provides the Luma Scientific Intelligence Platform, an AI-powered scientific R&D platform that connects research data, laboratory instruments, and workflows for life sciences organizations. The platform is built on structured, ontology-backed scientific data captured at the point of work and is offered through specialized modules covering biologics discovery, small molecule drug discovery, flow cytometry, lab workflow management, materials science, electronic lab notebooks, and data visualization.

Product overview

Dotmatics offers a unified scientific R&D platform architecture centered on Luma, an AI-powered platform that integrates multiple specialized products and modules. The Luma platform serves as the core scientific intelligence layer, embedding Luma Agent as an agentic AI co-scientist. Supporting modules include Luma Lab Connect for instrument integration, Luma Lab Workflow Management for process orchestration, and domain-specific solutions like BioGlyph Luma for protein design, Geneious Luma for antibody discovery, FCS Express Luma and OMIQ Luma for flow cytometry, and Luma Artificial Intelligence for predictive analytics. The portfolio covers solution areas for small molecule drug discovery, biologics drug discovery, and chemicals/materials science. Acquired brands including Geneious Prime, Geneious Biologics, FCS Express, OMIQ, and Virscidian are integrated into the ecosystem. Core capabilities include the Dotmatics Electronic Lab Notebook (ELN) for experiment capture and Dotmatics Vortex for data visualization.

Differentiator

Problem solved

Functional benefit

Brands

• Luma Scientific Intelligence Platform: AI-powered scientific R&D platform that serves as the foundation for scientific data management, analysis, and collaboration across life sciences research.

Products and services

• Luma Scientific Intelligence Platform Core AI-powered R&D platform connecting research data, instruments, and workflows, built on structured ontology-backed scientific data for life sciences organizations.
• Luma Agent Agentic AI co-scientist embedded in the Luma platform that plans and executes complex scientific work via natural language, reducing multi-day tasks to minutes with traceable, verifiable results.
• Luma Lab Workflow Management Software Lab workflow management system that orchestrates data and tasks across research, quality, and clinical operations for life sciences organizations.
• Luma Lab Connect Lab instrument integration software providing automated data capture from laboratory instruments and connectivity into the Luma platform.
• BioGlyph Luma Protein design and computational modeling platform enabling structure-based design and analysis of therapeutic proteins for biologics discovery.
• Geneious Luma End-to-end antibody discovery platform for biologics R&D, providing sequence analysis and integration with the Dotmatics ecosystem.
• FCS Express Luma Flow cytometry data analysis and reporting solution enabling visualization, interpretation, and sharing of flow cytometry results.
• OMIQ Luma Cloud-native flow cytometry analysis platform with ML-powered insights for automated gating, population identification, and anomaly detection.
• Luma Antibody and Protein Engineering Comprehensive solution for antibody and protein engineering workflows, from sequence design to characterization and optimization.
• Luma Flow Cytometry Centralized, scalable flow cytometry data analysis and reporting platform connecting panel design through analysis.
• Luma Artificial Intelligence AI and ML capabilities embedded across the Luma platform for intelligent insights, predictive analytics, and automated decision-making in scientific research.
• Luma Material Science Software Material analysis software providing data-driven R&D solutions for chemicals and materials science applications.
• Dotmatics Electronic Lab Notebook (ELN) Electronic lab notebook for capturing, managing, and sharing scientific experiments and data, with offline access and data export capabilities.
• Dotmatics Vortex Data visualization platform enabling interactive exploration and analysis of complex scientific datasets.
• Virscidian Analytical chemistry solutions for chromatography, mass spectrometry, and AI/ML analytics for small molecule research.

Quantifiable outcome

• Gartner predicts that governance requirements will stop 80 percent of agentic AI initiatives in healthcare and life sciences from progressing - Luma Agent addresses this with traceable, verifiable results

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability9 records

Feature10 records

Partnerships

Nine partnerships are on record, tiered core and flagship.

• DatabrickscoreTechnology or Integration · 13 May 2026Databricks powers Luma's data processing capabilities within the Luma Scientific Intelligence Platform. The integration enables scalable data processing for scientific research workflows and supports the platform's AI-powered analytics capabilities.
• Model Context Protocol (External AI Tools)coreTechnology or Integration · 13 May 2026Luma Agent integrates with external AI tools via the Model Context Protocol, enabling querying of experimental results and platform configuration. This allows interoperability with the broader AI/ML ecosystem for scientific research.
• Siemens AGflagshipOthers · 1 July 2025Siemens completed acquisition of Dotmatics for $5.1 billion enterprise value, integrating Dotmatics' Scientific Intelligence Platform into Siemens' Product Lifecycle Management portfolio. Creates end-to-end digital thread connecting research through production across Life Sciences market.
• VirscidiancoreStrategic or Co-development Partner · 25 September 2024Virscidian was acquired by Dotmatics to expand expertise in analytical chemistry and chromatography and mass spectrometry. The acquisition enhances lab data workflow automation and scientific research tools for small molecule research.
• EasyPanelcoreStrategic or Co-development Partner · 31 July 2024EasyPanel was acquired by Dotmatics to expand capabilities in flow cytometry solutions. The acquisition integrated EasyPanel's automated, algorithm-driven panel designer and smart recommendations into Dotmatics' product portfolio.
• SoftGeneticscoreStrategic or Co-development Partner · 1 June 2023SoftGenetics was acquired by Dotmatics in June 2023 to strengthen genomics data analysis capabilities for precision medicine research.
• Geneious PrimecoreTechnology or IntegrationDeep integration with Geneious Prime for bioinformatics workflows, providing industry-leading algorithms, advanced sequence analysis, and seamless Dotmatics integration for data-driven drug discovery.
• OMIQ (Flow Cytometry)coreTechnology or IntegrationCloud-native flow cytometry analysis partnership providing ML-powered insights for cellular analysis workflows.
• FCS ExpresscoreTechnology or IntegrationFCS Express by Dotmatics provides comprehensive flow cytometry data analysis and reporting capabilities.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Benchling: Cloud-native R&D platform for life sciences covering ELN, LIMS, molecular biology, and biologics workflows. Benchling is the closest direct competitor to Dotmatics in scientific R&D informatics for biotech and pharma customers.
• Genedata: Enterprise scientific informatics platform serving biopharma R&D with workflows for biologics, screening, and mass spectrometry. Competes head-to-head with Dotmatics in large pharma accounts.
• IDBS: Provider of ELN, LIMS, and scientific data management software for biopharmaceutical R&D. Overlaps directly with Dotmatics' ELN, workflow, and biologics modules.
• LabVantage Solutions: Enterprise LIMS provider for pharmaceutical, biotech, and industrial labs. Directly comparable to Dotmatics on lab data management and instrument integration capabilities.

Broad incumbents

• Veeva Systems: Dominant life sciences cloud platform spanning clinical, regulatory, and commercial. Veeva is a broad incumbent serving the same pharma customer base as Dotmatics, though it does not specialize in early-stage scientific R&D informatics.
• BIOVIA (Dassault Systèmes): Scientific informatics portfolio within Dassault Systèmes' 3DEXPERIENCE platform covering molecular modeling, lab execution, and regulatory. A broad incumbent in scientific software competing with Dotmatics in materials and life sciences R&D.
• Revvity Signals (formerly PerkinElmer Informatics): Signals software suite (formerly TIBCO Spotfire-based PerkinElmer informatics) covering scientific data analytics, ELN, and image analysis. Overlaps with Dotmatics' Vortex visualization and lab informatics products.

Emerging players

• Schrödinger: Physics-based computational chemistry and drug discovery platform. Adjacent competitor in small molecule discovery and a potential partner for Dotmatics' cheminformatics and molecular modeling workflows.
• Certara: Biosimulation and regulatory science software for drug development. Adjacent to Dotmatics' small molecule and regulatory compliance offerings, with overlap in pharma R&D customer base.
• Collaborative Drug Discovery (CDD): Cloud-based drug discovery informatics platform with chemical registration, assay management, and collaboration tools. Overlaps with Dotmatics' small molecule discovery module, particularly for academic and translational research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/dotmatics

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A15 records

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dotmatics